Back to Research Hub
MAIA Biotechnology, Inc.
MAIA
$1.30+0.03 (+2.36%)
MAIA Biotechnology, Inc., a clinical stage biotechnology company, engages in the discovery, development, and commercialization of therapies targeting cancer, primarily non-small cell lung cancer.
StreetsValue research for MAIA Biotechnology, Inc. (MAIA)
Members get the full report for MAIA Biotechnology, Inc.: a fair value estimate and valuation analysis, economic moat rating, growth and profitability factor grades, a bull and bear investment thesis, analyst price targets, insider and congressional trading activity, and which super investors own the stock.